Pharmacy Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacy, including details on drug stores, prescriptions, health care.

Volume 2 (2006), Issue 9 (September)

1. Out-of-hours co-operatives: general practitioner satisfaction with governance and working arrangements.
   Eur J Gen Pract, 12(1): 15-8. [Abstract] [Full-text]
2. Treatment algorithms from the pharmacist perspective.
   Pharmacotherapy, 26(9): 203S-6S. [Abstract] [Full-text]
3. The role of pharmacists in the evolution of health care: an open forum discussion.
   Pharmacotherapy, 26(9): 200S-2S. [Abstract] [Full-text]
4. Electrocardiographic and blood pressure effects of the ephedra-containing TrimSpa thermogenic herbal compound in healthy volunteers.
   Pharmacotherapy, 26(9): 1241-6. [Abstract] [Full-text]
5. Access to emergency contraception.
   Int J Gynaecol Obstet, 94(3): 301-9. [Abstract] [Full-text]
6. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
   Pharmacoepidemiol Drug Saf, 15(9): 675-82. [Abstract] [Full-text]
7. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications.
   Pharmacoepidemiol Drug Saf, 15(9): 641-52. [Abstract] [Full-text]
8. Brief report: assessing adherence to pediatric antiretroviral regimens using the 24-hour recall interview.
   J Pediatr Psychol, 31(9): 989-94. [Abstract] [Full-text]
9. Prevalence of the use of cancer related self-tests by members of the public: a community survey.
   BMC Cancer, 6: 215. [Abstract] [Full-text]
10. Post-traumatic stress disorder and diabetes: co-morbidity and outcomes in a male veterans sample.
    J Behav Med, 29(5): 411-8. [Abstract] [Full-text]
11. The coverage priorities of disabled adult Medi-Cal beneficiaries.
    J Health Care Poor Underserved, 17(3): 592-609. [Abstract] [Full-text]
12. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.
    Am J Health Syst Pharm, 63(18): 1736-44. [Abstract] [Full-text]
13. Monitoring of pharmacy staffing, workload, and productivity in community hospitals.
    Am J Health Syst Pharm, 63(18): 1728-34. [Abstract] [Full-text]
14. Medication management at home: medication risk factor prevalence and inter-relationships.
    J Clin Pharm Ther, 31(5): 485-91. [Abstract] [Full-text]
15. Parents report on stimulant-treated children in the Netherlands: initiation of treatment and follow-up care.
    J Child Adolesc Psychopharmacol, 16(4): 432-40. [Abstract] [Full-text]
16. Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate.
    J Pharm Biomed Anal, 42(3): 362-366. [Abstract] [Full-text]
17. Resource utilization of adults admitted to a large urban hospital with community-acquired pneumonia caused by Streptococcus pneumoniae.
    Chest, 130(3): 807-14. [Abstract] [Full-text]
18. Financial costs due to excess health risks among active employees of a utility company.
    J Occup Environ Med, 48(9): 896-905. [Abstract] [Full-text]
19. An evaluation of Oregon's evidence-based Practitioner-Managed Prescription Drug Plan.
    Health Aff (Millwood), 25(5): 1423-32. [Abstract] [Full-text]
20. Managing biotechnology in a network-model health plan: a U.S. private payer perspective.
    Health Aff (Millwood), 25(5): 1347-52. [Abstract] [Full-text]
21. Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study.
    Curr Med Res Opin, 22(9): 1757-64. [Abstract] [Full-text]
22. Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations.
    Curr Med Res Opin, 22(9): 1623-31. [Abstract] [Full-text]
23. Matching estimates of the impact of over-the-counter emergency birth control on teenage pregnancy.
    Health Econ, 15(9): 1021-32. [Abstract] [Full-text]
24. Feasibility and validity of a computer administered version of SEIQoL-DW.
    Qual Life Res. [Abstract] [Full-text]
25. Impact of recipient MELD score on resource utilization.
    Am J Transplant, 6(10): 2449-54. [Abstract] [Full-text]
26. Self-management profiles and metabolic outcomes in type 2 diabetes.
    J Adv Nurs, 56(1): 44-54. [Abstract] [Full-text]
27. Sex differences in gout epidemiology: evaluation and treatment.
    Ann Rheum Dis, 65(10): 1368-72. [Abstract] [Full-text]
28. Randomized trial of an intervention to facilitate recycling for relapsed smokers.
    Am J Prev Med, 31(4): 293-9. [Abstract] [Full-text]
29. Application of concentration ratios to analyze the phenomenon of "next-door" pharmacy in Taiwan.
    Clin Ther, 28(8): 1225-30. [Abstract] [Full-text]
30. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis.
    Clin Ther, 28(8): 1208-16. [Abstract] [Full-text]
31. The incidence of extravasation of vinca alkaloids supplied in syringes or mini-bags.
    J Oncol Pharm Pract, 12(2): 113-8. [Abstract] [Full-text]
32. 25 years of safe handling of cytotoxics (antineoplastics) in Israel.
    J Oncol Pharm Pract, 12(2): 83-90. [Abstract] [Full-text]
33. Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia.
    Cancer, 107(6): 1400-6. [Abstract] [Full-text]
34. A simple and rapid liquid chromatographic assay for evaluation of potentially counterfeit Tamiflu.
    J Pharm Biomed Anal, 42(4): 430-3. [Abstract] [Full-text]
35. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study.
    J Glaucoma, 15(5): 419-25. [Abstract] [Full-text]
36. Impact of alternative interventions on changes in generic dispensing rates.
    Health Serv Res, 41(5): 1876-94. [Abstract] [Full-text]
37. Pharmacists and travel advice for tropics in Lisbon (Portugal).
    J Travel Med, 13(5): 281-7. [Abstract] [Full-text]
38. Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning.
    Am J Health Syst Pharm, 63(19): 1821-7. [Abstract] [Full-text]
39. Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors.
    Int J Antimicrob Agents, 28(4): 273-9. [Abstract] [Full-text]
40. Prescribed doses of inhaled steroids in Dutch children: too little or too much, for too short a time.
    Br J Clin Pharmacol, 62(4): 383-90. [Abstract] [Full-text]
41. Improved therapeutic monitoring with several interventions: a randomized trial.
    Arch Intern Med, 166(17): 1848-54. [Abstract] [Full-text]
42. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
    Pharmacotherapy, 26(10): 1446-52. [Abstract] [Full-text]
43. Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapy.
    Pharmacotherapy, 26(10): 1369-78. [Abstract] [Full-text]
44. Are regional hospital pharmacies prepared for public health emergencies?
    Biosecur Bioterror, 4(3): 237-43. [Abstract] [Full-text]
45. Relationships between beliefs about medications and nonadherence to prescribed chronic medications.
    Ann Pharmacother, 40(10): 1737-42. [Abstract] [Full-text]
46. Supplementary prescribing: early experiences of pharmacists in Great Britain.
    Ann Pharmacother, 40(10): 1843-50. [Abstract] [Full-text]
47. A comparative study of consumer participation in mental health pharmacy education.
    Ann Pharmacother, 40(10): 1759-65. [Abstract] [Full-text]
48. Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs).
    Pharmacoepidemiol Drug Saf, 15(10): 719-25. [Abstract] [Full-text]
49. Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users.
    Pharmacoepidemiol Drug Saf, 15(10): 710-8. [Abstract] [Full-text]
50. Comparison between compliance of fluticasone propionate diskhaler and of fluticasone propionate diskus in adult bronchial asthma patients.
    Respiration, 73(5): 680-4. [Abstract] [Full-text]

© 2005-2008 Pharmacy Research Today. All Rights Reserved.